Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T18:53:13.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added above the trial record, directing visitors to transition updates and explaining that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-24T20:38:54.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:16:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the clinical trial record history is otherwise unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T22:13:58.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record history now shows a new revision label 'Revision: v3.7.0' and updates the contact information link text capitalization, with the prior 'Find Contact Information' entry and 'Revision: v3.6.6' removed.
    Difference
    0.1%
    Check dated 2026-09-19T22:19:20.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision label, v3.6.6, was added to the page history, replacing the previous v3.6.5. This indicates a minor update to the record's revision metadata without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-29T18:36:10.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.